326030 — SK Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- KR₩6tn
- KR₩5tn
- KR₩707bn
Brief: Sk Biopharmaceuticals Q2 Operating Profit 26 Billion Won, Swings To Profit From Year Earlier
Brief: Sk Biopharmaceuticals Wins 38.6 Billion Won Order
Brief: Sk Biopharmaceuticals Wins 49 Billion Won Order
Brief: Sk Biopharmaceuticals Q2 Operating Loss 19 Billion Won, Up 52.7% From Year Earlier
Brief: Sk Biopharmaceuticals Wins 37 Billion Won Order
Brief: Sk Biopharmaceuticals To Acquire Shares Worth 62 Billion Won In Proteovant Sciences Inc
Brief: Sk Biopharmaceuticals Wins 47 Billion Won Order
Brief: Sk Biopharmaceuticals Wins 14 Billion Won Order
Brief: Sk Biopharmaceuticals Co To Invest $20 Million In Lifesci Venture Partners Iii, Lp
Brief: Sk Biopharmaceuticals Wins 47 Billion Won Order
Brief: Sk Biopharmaceuticals Wins 31 Billion Won Order
Brief: Sk Biopharmaceuticals Co Wins 21 Billion Won Order
Brief: SK Biopharmaceuticals Q3 Operating Loss 9 Billion Won
Brief: Sk Biopharmaceuticals Wins 61.5 Billion Won Order
Brief: SK Biopharmaceuticals Co Signs $17 Million Deal With SK Life Science Inc To Sell Cenobamate In U.S.
Brief: SK Biopharmaceuticals, Eurofarma Enter Into Licensing Agreement For Cenobamate In Latin America
Brief: SK Biopharmaceuticals Says To Acquire 177 Billion Won Worth Of Shares In Ignis Therapeutics
WHO expects decision on emergency listing for Chinese vaccines soon (updated)
Vaccine developer SK Bioscience to raise $1.3 bln in S.Korea's largest IPO since 2017 (updated)